Contango Ore Reports FY Loss and New Gold Discovery
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy CTGO?
Source: seekingalpha
- Financial Loss: Contango Ore reported a FY GAAP EPS of -$2.80, indicating significant financial challenges that may impact investor confidence and lead to stock price volatility.
- New Gold Discovery: The company announced a high-grade gold discovery at the Lucky Shot project, although specific metrics were not disclosed, this finding could provide new growth opportunities for future mineral development and enhance the company's competitive position in the gold market.
- Financing Plan: Contango Ore plans to raise approximately $50 million through a stock offering, which will support strategic initiatives including the buyback of gold hedge contracts, aimed at optimizing the financial structure and increasing shareholder value.
- Market Reaction: Despite the financial loss, the new discovery and financing plan may improve market perception of Contango Ore in the long term, especially against the backdrop of fluctuating gold prices.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CTGO?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CTGO
Wall Street analysts forecast CTGO stock price to rise
2 Analyst Rating
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 23.340
Low
35.00
Averages
35.00
High
35.00
Current: 23.340
Low
35.00
Averages
35.00
High
35.00
About CTGO
Contango ORE, Inc. is engaged in the exploration of gold and associated minerals in Alaska. The Company holds a 30% interest in the Peak Gold JV, which leases approximately 675,000 acres of land for exploration and development on the Manh Choh project, with the remaining 70% owned by KG Mining (Alaska), Inc., an indirect subsidiary of Kinross Gold Corporation, operator of the Peak Gold JV. It also has a lease on the Johnson Tract project from the underlying owner, CIRI Native Corporation, a lease on Lucky Shot project from the underlying owner, Alaska Hardrock Inc. and through its subsidiary has 100% ownership of approximately 8,600 acres of peripheral State of Alaska mining claims. It also owns a 100% interest in an additional approximately 145,000 acres of State of Alaska mining claims through its wholly owned subsidiary, which gives the Company an exclusive right to explore and develop minerals on these lands. The Company also owns Golden Zone and Amanita NE gold properties.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Contango ORE Reports FY 2025 Performance and Strategic Outlook
- Production and Financial Overview: In FY 2025, Contango ORE produced 60,200 gold equivalent ounces from the Manh Choh mine, reporting a net loss of $36.1 million, yet achieving an adjusted net income of $73 million, demonstrating resilience amid challenges.
- Cash Flow and Debt Management: As of December 31, 2025, the company's unrestricted cash position was $64.8 million, a significant increase from $20 million in 2024, while also repaying $37.5 million of its credit facility, effectively reducing its debt burden.
- Lucky Shot Project Progress: Contango commenced an underground drilling program at the Lucky Shot project in Q4 2025, aiming for an annual production target of 40,000 to 50,000 ounces, with a production decision expected in 2027, reflecting confidence in future growth.
- Dolly Varden Merger Plans: The merger with Dolly Varden is anticipated to close by the end of March 2026, with the new entity focusing on silver and gold production, further enhancing market competitiveness.
See More
Contango Ore Reports FY Loss and New Gold Discovery
- Financial Loss: Contango Ore reported a FY GAAP EPS of -$2.80, indicating significant financial challenges that may impact investor confidence and lead to stock price volatility.
- New Gold Discovery: The company announced a high-grade gold discovery at the Lucky Shot project, although specific metrics were not disclosed, this finding could provide new growth opportunities for future mineral development and enhance the company's competitive position in the gold market.
- Financing Plan: Contango Ore plans to raise approximately $50 million through a stock offering, which will support strategic initiatives including the buyback of gold hedge contracts, aimed at optimizing the financial structure and increasing shareholder value.
- Market Reaction: Despite the financial loss, the new discovery and financing plan may improve market perception of Contango Ore in the long term, especially against the backdrop of fluctuating gold prices.
See More
Contango Ore Named Among Top Gold Stocks by Analysts
- Significant Project Progress: Contango Ore has made substantial advancements in its underground drilling program at the Lucky Shot project in Alaska, with initial results confirming the continuity of the historically mined Lucky Shot vein, which is expected to enhance understanding of other veins and strengthen the company's competitive position in the gold market.
- Successful Financing: On February 12, the company completed an underwritten offering of 1.67 million shares, raising $50 million in gross proceeds, with plans to allocate approximately $45 million for buying back gold hedge contracts and $700,000 for purchasing gold put contracts, thereby enhancing financial flexibility.
- Future Planning: Contango Ore aims to deliver a feasibility study for the Lucky Shot project in H1 2027, further validating the geological model and advancing the commercialization process, demonstrating the company's confidence in future development.
- Strategic Partnerships: Contango Ore holds a 30% interest in the Peak Gold Joint Venture, which is expected to commence production in 2024, indicating the company's potential and strategic positioning in Alaska's mining development.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Shareholder Rights Investigation: Halper Sadeh LLC is investigating RAPT Therapeutics, Inc.'s sale to GSK plc for $58.00 per share, raising concerns about potential violations of shareholder rights and encouraging shareholders to understand their options.
- Merger Transaction Review: The merger between Contango ORE, Inc. and Dolly Varden Silver Corporation will result in Contango shareholders owning approximately 50% of the combined entity, prompting Halper Sadeh LLC to assess whether this transaction serves the best interests of shareholders.
- Shareholder Equity Protection: Tamboran Resources Corporation's merger with Falcon Oil & Gas Ltd. will allow Tamboran shareholders to hold 73.2% of the combined company, with Halper Sadeh LLC urging shareholders to be aware of potential equity losses.
- Legal Support Services: Amicus Therapeutics, Inc. is being sold to BioMarin Pharmaceutical Inc. for $14.50 per share, and Halper Sadeh LLC offers no-cost legal consultations to assist shareholders in protecting their rights.
See More
Monteverde Law Firm Investigates RAPT and Others for Shareholder Recovery
- Shareholder Recovery Investigation: Monteverde & Associates is investigating RAPT Therapeutics, Inc.'s sale to GSK plc, with RAPT shareholders expected to receive $58.00 per share in cash, which could significantly enhance shareholder returns and bolster investor confidence.
- Amicus Transaction Update: In the proposed sale of Amicus Therapeutics, Inc. to BioMarin Pharmaceutical Inc., Amicus shareholders are anticipated to receive $14.50 per share in cash, with a shareholder vote scheduled for March 3, 2026, potentially impacting the company's future market performance.
- Merger Voting Arrangement: Tamboran Resources Corporation's merger with Falcon Oil & Gas Ltd. will result in Tamboran shareholders owning 73.2% of the combined entity, with a shareholder vote set for March 4, 2026, indicating the company's strategic positioning in industry consolidation.
- Contango Merger Details: The merger between Contango Ore, Inc. and Dolly Varden Silver Corporation will allow Contango shareholders to own 50% of the combined company, with a shareholder vote scheduled for March 17, 2026, which may present new growth opportunities for shareholders.
See More
Contango ORE Closes $50 Million Stock Offering
- Successful Stock Offering: Contango ORE has closed its underwritten offering of 1,678,206 shares at $24.96 each, attracting two institutional investors and generating approximately $50 million in gross proceeds, significantly strengthening the company's capital base.
- Clear Use of Proceeds: The company intends to allocate about $45 million for repurchasing gold hedge contracts and $700,000 for purchasing gold put contracts for downside protection, a strategy that will help mitigate the impact of market volatility on its financials.
- Strong Underwriting Team: Canaccord Genuity acted as the Sole Bookrunner for the offering, with Cantor, National Bank of Canada Capital Markets, and ATB Cormark Capital Markets serving as Co-Managers, reflecting strong market confidence and support for Contango.
- Effective Registration Statement: The offering was made under an effective shelf registration statement on Form S-3 declared effective on November 27, 2024, ensuring compliance and transparency, which is likely to enhance investor confidence in the company's future prospects.
See More
Contango ORE Reports FY 2025 Performance and Strategic Outlook
- Production and Financial Overview: In FY 2025, Contango ORE produced 60,200 gold equivalent ounces from the Manh Choh mine, reporting a net loss of $36.1 million, yet achieving an adjusted net income of $73 million, demonstrating resilience amid challenges.
- Cash Flow and Debt Management: As of December 31, 2025, the company's unrestricted cash position was $64.8 million, a significant increase from $20 million in 2024, while also repaying $37.5 million of its credit facility, effectively reducing its debt burden.
- Lucky Shot Project Progress: Contango commenced an underground drilling program at the Lucky Shot project in Q4 2025, aiming for an annual production target of 40,000 to 50,000 ounces, with a production decision expected in 2027, reflecting confidence in future growth.
- Dolly Varden Merger Plans: The merger with Dolly Varden is anticipated to close by the end of March 2026, with the new entity focusing on silver and gold production, further enhancing market competitiveness.
See More
Contango Ore Reports FY Loss and New Gold Discovery
- Financial Loss: Contango Ore reported a FY GAAP EPS of -$2.80, indicating significant financial challenges that may impact investor confidence and lead to stock price volatility.
- New Gold Discovery: The company announced a high-grade gold discovery at the Lucky Shot project, although specific metrics were not disclosed, this finding could provide new growth opportunities for future mineral development and enhance the company's competitive position in the gold market.
- Financing Plan: Contango Ore plans to raise approximately $50 million through a stock offering, which will support strategic initiatives including the buyback of gold hedge contracts, aimed at optimizing the financial structure and increasing shareholder value.
- Market Reaction: Despite the financial loss, the new discovery and financing plan may improve market perception of Contango Ore in the long term, especially against the backdrop of fluctuating gold prices.
See More
Contango Ore Named Among Top Gold Stocks by Analysts
- Significant Project Progress: Contango Ore has made substantial advancements in its underground drilling program at the Lucky Shot project in Alaska, with initial results confirming the continuity of the historically mined Lucky Shot vein, which is expected to enhance understanding of other veins and strengthen the company's competitive position in the gold market.
- Successful Financing: On February 12, the company completed an underwritten offering of 1.67 million shares, raising $50 million in gross proceeds, with plans to allocate approximately $45 million for buying back gold hedge contracts and $700,000 for purchasing gold put contracts, thereby enhancing financial flexibility.
- Future Planning: Contango Ore aims to deliver a feasibility study for the Lucky Shot project in H1 2027, further validating the geological model and advancing the commercialization process, demonstrating the company's confidence in future development.
- Strategic Partnerships: Contango Ore holds a 30% interest in the Peak Gold Joint Venture, which is expected to commence production in 2024, indicating the company's potential and strategic positioning in Alaska's mining development.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Shareholder Rights Investigation: Halper Sadeh LLC is investigating RAPT Therapeutics, Inc.'s sale to GSK plc for $58.00 per share, raising concerns about potential violations of shareholder rights and encouraging shareholders to understand their options.
- Merger Transaction Review: The merger between Contango ORE, Inc. and Dolly Varden Silver Corporation will result in Contango shareholders owning approximately 50% of the combined entity, prompting Halper Sadeh LLC to assess whether this transaction serves the best interests of shareholders.
- Shareholder Equity Protection: Tamboran Resources Corporation's merger with Falcon Oil & Gas Ltd. will allow Tamboran shareholders to hold 73.2% of the combined company, with Halper Sadeh LLC urging shareholders to be aware of potential equity losses.
- Legal Support Services: Amicus Therapeutics, Inc. is being sold to BioMarin Pharmaceutical Inc. for $14.50 per share, and Halper Sadeh LLC offers no-cost legal consultations to assist shareholders in protecting their rights.
See More
Monteverde Law Firm Investigates RAPT and Others for Shareholder Recovery
- Shareholder Recovery Investigation: Monteverde & Associates is investigating RAPT Therapeutics, Inc.'s sale to GSK plc, with RAPT shareholders expected to receive $58.00 per share in cash, which could significantly enhance shareholder returns and bolster investor confidence.
- Amicus Transaction Update: In the proposed sale of Amicus Therapeutics, Inc. to BioMarin Pharmaceutical Inc., Amicus shareholders are anticipated to receive $14.50 per share in cash, with a shareholder vote scheduled for March 3, 2026, potentially impacting the company's future market performance.
- Merger Voting Arrangement: Tamboran Resources Corporation's merger with Falcon Oil & Gas Ltd. will result in Tamboran shareholders owning 73.2% of the combined entity, with a shareholder vote set for March 4, 2026, indicating the company's strategic positioning in industry consolidation.
- Contango Merger Details: The merger between Contango Ore, Inc. and Dolly Varden Silver Corporation will allow Contango shareholders to own 50% of the combined company, with a shareholder vote scheduled for March 17, 2026, which may present new growth opportunities for shareholders.
See More
Contango ORE Closes $50 Million Stock Offering
- Successful Stock Offering: Contango ORE has closed its underwritten offering of 1,678,206 shares at $24.96 each, attracting two institutional investors and generating approximately $50 million in gross proceeds, significantly strengthening the company's capital base.
- Clear Use of Proceeds: The company intends to allocate about $45 million for repurchasing gold hedge contracts and $700,000 for purchasing gold put contracts for downside protection, a strategy that will help mitigate the impact of market volatility on its financials.
- Strong Underwriting Team: Canaccord Genuity acted as the Sole Bookrunner for the offering, with Cantor, National Bank of Canada Capital Markets, and ATB Cormark Capital Markets serving as Co-Managers, reflecting strong market confidence and support for Contango.
- Effective Registration Statement: The offering was made under an effective shelf registration statement on Form S-3 declared effective on November 27, 2024, ensuring compliance and transparency, which is likely to enhance investor confidence in the company's future prospects.
See More
